Why is "Cell engineering" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-05-27 19:24:18
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Cell_engineering entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-05-27 and was most recently seen on 2026-05-27.
Wikipedia Overview
Cell engineering is the purposeful process of adding, deleting, or modifying genetic sequences in living cells to achieve biological engineering goals such as altering cell production, changing cell growth and proliferation requirements, adding or removing cell functions, and many more. Cell engineering often makes use of recombinant DNA technology to achieve these modifications as well as closely related tissue engineering methods. Cell engineering can be characterized as an intermediary level in the increasingly specific disciplines of biological engineering which includes organ engineering, tissue engineering, protein engineering, and genetic engineering.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Simultaneous orthogonal cell engineering by a single CRISPR-Cas9 polyfunctional editor - Nature
-
Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering - Genetic Engineering and Biotechnology News
-
Portal Biotechnologies Raises $9 Million To Expand Cell Engineering Platform - Pulse 2.0
-
Big Pharma Makes M&A Moves to Secure Positions in In Vivo Cell Engineering - BioInformant
-
Cell Engineering and Hematologic Immunotherapy Group - VHIO
-
VectorBuilder Partners With MaxCyte® to Advance Clinical-Grade Cell Engineering - Business Wire
-
Portal Biotechnologies Raises $9 Million to Scale Cell Engineering Platform - citybiz
-
Stem cell engineering breakthrough paves way for next-generation living drugs - UBC Faculty of Medicine
-
Press Release Service: From Blurry to 4K DNA: Dante Omics AI, Rockefeller University, Giunta Lab and Global Partners Assemble the Most Complete Genome for the RPE-1 Cell Line – the Standard for Complex Cell Engineering Experiments - CRISPR Medicine News
-
CREATE Medicines Unveils All-RNA T-Cell Engineering Platform: RetroT Enables Site-Specific, Durable CAR integration In Vivo - PR Newswire
-
Antigen-presenting nanoparticles for in vivo CAR T cell engineering - Nature
-
Large-Scale T Cell Editing Using Nonviral Genome Editing Tools - the-scientist.com
-
CAR T-cell engineering and cancer - sdu.dk
-
STRM.BIO Raises $8 Million in Series Seed 2 Financing to Advance Non-Viral Gene Delivery Platform for In Vivo Cell Engineering and Gene Therapy - PR Newswire
-
Human pluripotent stem cell engineering with CRISPR–Cas9 for Parkinson’s disease - Nature
-
Michel Sadelain Appointed Inaugural Director of the Columbia Initiative in Cell Engineering and Therapy - Columbia University
-
Vycellix Prepares for First-in-Human Study of Novel Allogeneic Cell Therapy Powered by Its Universal Cell Engineering Platform - Business Wire
-
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy - PR Newswire
-
The dawn of in vivo immune cell engineering in oncology - Nature
-
In vivo human T cell engineering with enveloped delivery vehicles - Nature
-
Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration - Nature
-
Transitioning from native to synthetic receptors: broadening T-cell engineering and beyond - Nature
-
Synthetic biology-inspired cell engineering in diagnosis, treatment and drug development - Nature
-
The emerging era of cell engineering: Harnessing the modularity of cells to program complex biological function - Science | AAAS
-
Circular Single-Stranded DNA Enables Efficient Non-Viral Immune Cell Engineering: Implications for CAR-T Cell Therapy - CRISPR Medicine News
-
Cas12a-knock-in mice for multiplexed genome editing, disease modelling and immune-cell engineering - Nature
-
Translational Research in NK Cell Engineering - Targeted Oncology
-
Robust genome and cell engineering via in vitro and in situ circularized RNAs - Nature
-
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism - Wiley Online Library
-
Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering - Nature
-
Stem Cell Engineering and Biology Program Hosts First Symposium - University of California, Merced
-
Intellia Therapeutics Presents New Data on Expanded Cell Engineering Capabilities Utilizing Base Editors - Intellia Therapeutics
-
Versioning biological cells for trustworthy cell engineering - Nature
-
The intersection of bottom-up synthetic cell engineering and nanobiotechnology - Nature
-
Gene Writer Enables Stable In Vivo CAR T-Cell Engineering Through RNA Delivery - Pharmacy Times
-
RNASeq highlights ATF6 pathway regulators for CHO cell engineering with different impacts of ATF6β and WFS1 knockdown on fed-batch production of IgG1 | Scientific Reports - Nature
-
Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy - Frontiers
-
B cell engineering in vivo: Accelerating induction of broadly neutralizing antibodies against HIV-1 infection - Nature
-
A step toward stem cell engineering in vivo - Science | AAAS
-
Stem Cell Engineering - UCLA Health
-
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors - Nature
-
Fighting cancer using a novel cell engineering technology - Roche
-
DARPin-LNP conjugates could enable in vivo cell engineering - bioxconomy.com
-
CLASH enables large-scale parallel knock-in for cell engineering - Nature
-
Synthego, bit.bio Collaborate on Multiplexed Cell Engineering Platform - Genetic Engineering and Biotechnology News
-
Therapeutic T cell engineering - Nature
-
Bacterial encapsulins as orthogonal compartments for mammalian cell engineering - Nature
-
Capstan Therapeutics launches with $165 million for cell engineering - Chemical & Engineering News
-
Portal Bio and Multiply Labs Collaborate to Accelerate Cell Engineering - Genetic Engineering and Biotechnology News
-
Advances in cell engineering therapies: where are we in 2020? - BioTechniques
-
4th In Vivo Cell Engineering & Gene Editing Summit - pharmaphorum
-
MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments - News-Medical
-
MaxCyte celebrates 25 years of innovation driving cell engineering-based therapeutics - News-Medical
-
Portal Biotechnologies: Cell Engineering Platform Company Raises $7 Million (Seed) - Pulse 2.0
-
CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow - PR Newswire
-
Mekonos closes Novartis-backed $25M series A for cell engineering platform - Fierce Biotech
-
The future of single-cell microfluidics in cell engineering - Labiotech.eu
-
Portal Biotechnologies and Multiply Labs Announce Partnership to Automate Cell Engineering In Cell Therapy Manufacturing - Business Wire
-
EditCo Bio Launches with Acquisition of Synthego's Cell Engineering Divisions to Boost CRISPR Market Innovations - BioPharma APAC
-
CapstanTx secures $165 million to deliver precise in vivo cell engineering - pharmaphorum
-
SQZ founder Armon Sharei opens Portal to simplify intracellular delivery - Fierce Biotech
-
Ginkgo Bioworks picks up Bitome's AI to bolster its cell engineering platform - Fierce Biotech
-
Center for Cell Engineering Sixth Annual Retreat - Memorial Sloan Kettering Cancer Center
-
WPI receives $877K to support cell engineering program - Worcester Business Journal
-
Cell engineering - European Space Agency
-
Capstan Therapeutics Launches with $165M for Precise in Vivo Cell Engineering - BioSpace
-
Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors - Nature
-
Multiplexed high-throughput localized electroporation workflow with deep learning–based analysis for cell engineering - Science | AAAS
-
Mini CRISPR system promises easier cell engineering, gene therapy - upi.com
-
Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell's Gene Editing Platform and Oncology Product Portfolio - PR Newswire
-
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles - Nature
-
Presenting a Universal Cell Engineering Solution - Technology Networks
-
Bioengineering cells to support new capabilities - Stanford Medicine Magazine
-
A New Form of Stem-Cell Engineering Raises Ethical Questions (Published 2017) - The New York Times
-
Former Juno execs unveil Sana, a new cell engineering biotech that’s reportedly raising more than $800M - GeekWire
-
Ginkgo Bioworks Taps Cell-Engineering Startup to Advance Services - WSJ
-
Dragon Ball’s Fusion Technique: Cell Engineering Expert Explains How It Works! - Animehunch
-
Girl, 13, ‘leukaemia-free’ after world-first use of cell engineering therapy - The Independent
-
Lab platform Opentrons closes $200M series C to build out robotics, diagnostics, cell engineering services - Fierce Biotech
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.